Trv Gp Iv, LLC Pliant Therapeutics, Inc. Put Options Transaction History

Trv Gp Iv, LLC

  • $80.2 Million
  • Q4 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $65.7M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Trv Gp Iv, LLC Portfolio

Follow Trv Gp Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trv Gp Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trv Gp Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email